In contrast to AbbVie, Pfizer ( PFE 2.29%) stands out as more of a turnaround opportunity, offering investors the chance to ...

Pfizer yields 6.53% and trades at 9x earnings, while Altria offers 7.58% at 10.1x earnings. Pfizer's troubling 221% payout ...

We recently published a list of the 8 Best Dividend Leaders to Buy According to Wall Street Analysts. In this article, we are ...

Plenty of high-performing growth stocks pay dividends -- such as Apple and Nvidia -- and though their dividend yields can be ...

Pfizer's oncology promises are several years from being actualized. Read why investors shouldn't assume that a sustained ...

Amid a fall season characterized by restive shareholders seeking an activist bid to unseat senior management and change the ...

These five blue-chip dividend stocks are among the best in their respective sectors and are rated Buy at major Wall Street ...

Dividend-paying stocks provide investors with consistent income in turbulent markets, especially as payouts grow over time.

Shares of Pfizer (NYSE: PFE) recently marched higher in response to a dividend payout raise and a forward-looking ...

I asked followers to select a single stock for a 10-year investment horizon. Check out the long-term prospects of each stock ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other best dividend leaders to buy. Investors have long been drawn to dividend stocks due to their ...

We recently published a list of the 10 Best Stocks to Buy and Hold For 3 Years. In this article, we are going to take a look ...